Sign Up to like & get
recommendations!
0
Published in 2019 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.1616
Abstract: Dual antiplatelet therapy (DAPT) is standard in acute coronary heart disease but confers a bleeding risk. To compare the effects of ticagrelor‐monotherapy with ticagrelor‐based DAPT on hemostatic system activation, we conducted a randomized controlled trial…
read more here.
Keywords:
trial;
ticagrelor;
ticagrelor based;
effects ticagrelor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.707722
Abstract: Background: The impact of ticagrelor-based dual antiplatelet therapy (DAPT) on acute coronary syndrome (ACS) in patients with chronic kidney disease (CKD) remains unclear. Methods: Data on a total of 1,067 ACS patients with CKD including…
read more here.
Keywords:
coronary syndrome;
ticagrelor;
based dapt;
disease ... See more keywords